Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice. - Wikidata - awgldk - TriplyDB

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.

http://www.wikidata.org/entity/Q37381690

about

Selective enhancement of donor hematopoietic cell engraftment by the CXCR4 antagonist AMD3100 in a mouse transplantation model.Effects of spleen status on early outcomes after hematopoietic cell transplantation.Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution.67 kDa laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach?Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment.Spontaneous subcapsular splenic hematoma associated with filgrastim in a patient undergoing allogeneic hematopoietic stem cell transplantation.To G or not to G: is this still a question in allogeneic transplantation?

P2860

Q33623571-2A4305CF-A60F-44FB-888E-B02FFBC067CC Q36712192-1709694E-8FD6-47CE-8D42-5137D2CF38CB Q37639107-278C1EC6-2C90-44FF-9FA8-A00960F398FB Q39023088-BC6423A2-2BC9-4913-82AE-57FB4EFD340F Q41663868-7FF6090C-AB2C-49C7-96B2-349546012B02 Q41761236-490A03D9-4170-4617-BDD9-D75A69D542A8 Q51068710-2E6813DF-CBC0-4DBF-89B8-7D242C016B30 Q51772784-70580E67-61F6-4ACD-AF2B-8EA1228E1A15

P2860

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.

http://www.wikidata.org/entity/Q37381690

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Filgrastim support in allogene ...... ications for current practice.

@en

Filgrastim support in allogene ...... ications for current practice.

@nl

type

label

Filgrastim support in allogene ...... ications for current practice.

@en

Filgrastim support in allogene ...... ications for current practice.

@nl

prefLabel

Filgrastim support in allogene ...... ications for current practice.

@en

Filgrastim support in allogene ...... ications for current practice.

@nl

P1433

Q37381690-0E0E7AD7-ED33-4C46-9624-1D824FA99C9E

P1476

Q37381690-EF7DDECD-0250-4EA2-B926-6FFDC2CE5CC8

P2093

Q37381690-9599C0D0-C93B-43EE-AB8B-13CBCA865EBB

Q37381690-FF1E9EBE-874A-440D-8671-AA7401ABEC9E

P2860

Q37381690-01117FBC-1D0A-4DBC-8AC6-24E56F7BAA15

Q37381690-3658B15C-437D-4606-B966-C721E98D8DD0

Q37381690-3AE18BFF-B988-475B-A048-DF527E35B7A7

Q37381690-3C300EB9-6FB5-489E-BEA2-893E2E56EE60

Q37381690-567BC8B9-7E4E-4626-BDB6-6EB090CF8A98

Q37381690-5E945025-93D7-46BA-BFDC-78A1DFFBB25D

Q37381690-659B5BFC-1433-4EC6-9B5E-673548BE0AE8

Q37381690-7C7FCEB6-89D5-4A4C-8D05-9BF54C900E0D

Q37381690-7D1E01DE-7ADD-4752-83B7-085C02708AA2

Q37381690-911D9586-0FEC-4A6A-81B2-D18482D0A035

P2888

Q37381690-D0959ACA-511B-484B-9814-49A5CA4EF296

P304

Q37381690-05E6A5D3-DF4D-4FFF-A01A-BD5679303B6B

P31

Q37381690-B7665225-8BD4-431D-BD92-0C5DCB38DFA3

P356

Q37381690-9078C2D5-BD8A-483F-8622-F008F9AFB0CB

P407

Q37381690-FF268C9B-17FB-4705-A06D-6FB5D0595070

P433

Q37381690-DDDFC075-E2B2-495B-8FB4-FBEF68A8F1E1

P478

Q37381690-4EC0BEEA-E76E-49BF-BBF9-A28C57D56F46

P577

Q37381690-B9027D69-9BBF-4965-91F6-D11016413EFA

P5875

Q37381690-901B5B5D-6104-429C-93E8-9560F905DB3F

P698

Q37381690-9483DD2D-087E-40E6-821A-C29E01BDB660

P356

P1433

Bone Marrow Transplantation

P1476

Filgrastim support in allogene ...... ications for current practice.

@en

P2093

M Battiwalla

http://www.w3.org/2001/XMLSchema#string

P L McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.

Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance.

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

P2888

P304

351-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.443

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23964679

http://www.w3.org/2001/XMLSchema#string

P698

19182834

http://www.w3.org/2001/XMLSchema#string